KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $25,342,000 | +32.1% | 244,444 | 0.0% | 0.01% | +30.0% |
| Q1 2017 | $19,186,000 | +39.8% | 244,444 | -20.2% | 0.01% | +42.9% |
| Q4 2016 | $13,727,000 | -39.9% | 306,144 | -25.1% | 0.01% | -41.7% |
| Q3 2016 | $22,838,000 | +11.7% | 408,844 | 0.0% | 0.01% | +9.1% |
| Q2 2016 | $20,442,000 | +10.6% | 408,844 | +1.6% | 0.01% | +10.0% |
| Q1 2016 | $18,476,000 | -25.0% | 402,444 | +0.7% | 0.01% | -16.7% |
| Q4 2015 | $24,632,000 | +8.5% | 399,744 | -1.9% | 0.01% | +9.1% |
| Q3 2015 | $22,692,000 | -8.7% | 407,544 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $24,848,000 | +5.7% | 407,544 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $23,507,000 | -6.9% | 407,544 | -6.9% | 0.01% | 0.0% |
| Q4 2014 | $25,239,000 | +148.8% | 437,644 | +23.0% | 0.01% | +120.0% |
| Q3 2014 | $10,144,000 | – | 355,944 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |